Phorbol ester effects on splenic lymphocyte composition cytotoxic T cell activities of SSIN mice: A strain deficient in CD8+ T cells

Carcinogenesis

Volumn 17, Issue 12, 1996, Pages 2617-2624

  Yoon, Hyunah L ^a,c   Singh, Kameshwar P ^a   Ratner, Stuart ^b   Reiners Jr , John J ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HAPLOTYPE; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SPLEEN LYMPHOCYTE; THYMOCYTE;

ANIMALS; CD4-CD8 RATIO; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOPHENOTYPING; ISOANTIGENS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TETRADECANOYLPHORBOL ACETATE;

EID: 0030449111     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.12.2617     Document Type: Article

References (52)

1. Winberg,L.D., Budunova,I.V., Warren,B.S., Iyer,R.P. and Slaga,T.J. (1995) Mechanism of skin tumor promotion and progression. In Mukhtar,H, (ed.), Skin Cancer: Mechanism and Human Relevance. CRC Press, Boca Raton, FL, pp. 113-120.
2. Galli,S.J., Wershil,BK. and Mekori,Y.A. (1987) Analysis of mast cell function in biological responses not involving IgE. Int. Arch. Allergy Appl. Immunol., 82, 269-271.
3. Aldaz,C.M., Conti,C.J., Gimenez,I.B., Slaga,T.J. and Klein-Szanto,A.J.P. (1985) Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res., 45, 2753-2759.
4. Lewis,J.G. and Adams,D.O. (1987) Early inflammatory changes in the skin of SENCAR and C57BL/6 mice following exposure of 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis, 8, 889-898.
5. Baxter,C.S., Andringa,A., Chalfin,K. and Miller,M.L. (1989) Comparative histomorphometric changes in SENCAR mouse epidermis in response to multiple treatments with complete and stage-specific tumor promoting agents. Carcinogenesis, 10, 1855-1861.
6. + cells. Carcinogenesis, 12, 1017-1021.
7. Kodari,E. and Reiners,J.J.,Jr (1993) Cutaneous antigen presentation is inhibited by topical application of TPA. J. Invest. Dermatol., 100, 567.
8. Halliday,G.M., MacCarrick,G.R. and Muller,H.K. (1988) Suppressor cell activation and enhanced skin allograph survival after tumor promoter but not initiator induced depletion of cutaneous Langerhans cells. J. Invest. Dermatol., 90, 293-297.
9. Czerniecki,B., Witz,G., Rilly,C. and Gad,S.C. (1988) The development of contact hypersensitivity in mouse skin is suppressed by tumor promoters. J. Appl. Toxicol., 8, 1-8.
10. Kodari,E., Pavone,A. and Reiners,J.J.,Jr (1991) Induction of suppressor T cells and inhibition of contact hypersensitivity in mice by 12-O-tetradecanoylphorbol-13-acetate and its analogs. J. Invest. Dermatol., 96, 864-870.
11. Kodari,E., Pavone,A. and Reiners,J.J.,Jr (1993) Differential modulation of contact hypersensitivity and delayed hypersensitivity reactions by topical application of 12-O-tetradecanoylphorbol-13-acetate. Immunopharmacol. Immunotoxicol., 15, 639-647.
12. Grabbe,S., Bruvers,S., Gallo,R.L., Knisely,T.L., Nazareno,R. and Granstein,R.D. (1991) Tumor antigen presentation by murine epidermal cells. J. Immunol., 146, 3656-3661.
13. Grabbe,S., Bruvers,S. and Granstein,R.D. (1992) Effects of immunomodulatory cytokines on the presentation of tumor-associated antigens by epidermal Langerhans cells. J. Invest. Dermatol., 99, 66S-68S.
14. Pehamberger,H., Gazze-Stingl,L.A., Pogantsch,S., Steiner,G., Wolf,K. and Stingl,G. (1982) Generation of cytotoxic T lymphocytes against alloantigens and TNP-modified syngeneic cells by epidermal cells: requirement for Ia-bearing Langerhans cells. Immunobiology, 163, 122-127.
15. Cerottini,J.C. and Brunner,T.K. (1974) Cell mediated cytotoxicity, allograft rejection and tumor immunity. Adv. Immunol., 18, 67-132.
16. Feffer,A. and Goldstein,A.L. (1982) The potential role of T cells in cancer therapy. In Goldstein,A. and Feffer,A. (eds), Progress in Cancer Research and Therapy. Raven Press, New York, NY, Vol. 22.
17. Liu,B., Podack,E.R., Allison,J.P. and Malck,T.R. (1996) Generation of primary tumor-specific CTL in vitro to immunogeneic and poorly immunogeneic mouse tumors. J. Immunol., 156, 1117-1125.
18. Fischer,S.M., O'Connell,F.J., Conti,C.J., Tacker,K.C., Fries,J.W., Patrick,K.E., Adams,L.M. and Slaga,T.J. (1987) Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis, 8, 421-424.
19. Giminez-Conti,I.B., Bianchi,A.B., Fischer,S.M., Reiners,J.J.,Jr, Conti,C.J. and Slaga,T.J. (1992) Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res., 52, 3432-3235.
20. Andreotti,P.E. (1982) Phorbol ester tumor promoter modulation of alloantigen-specitic T lymphocyte response. J. Immunol., 129, 91-96.
21. Herberman,R.B. and Ortaldo,J.R (1981) Natural killer cells: their role in defenses against disease. Science, 214, 24-30.
22. Herberman,R.B. et al. (1979) Natural killer cells: characteristics and regulation of activity. Immunol Rev., 44, 43-70.
23. Klein,J. (1986) lmmunology: The Science of Self-Nonself Discrimination. John Wiley & Sons., New York, NY.
24. 1) mice. Carcinogenesis, 10, 1107-1111.
25. 1) mice. Carcinogenesis, 9, 1943-1951.
26. Thomas,P., Ratajczak,H., Demetral,D., Hagen,K. and Baron,R. (1990) Aldicarb immunotoxicity: functional anlaysis of cell-mediated immunity and quantitation of lymphocyte subpopulations. Fundam. Appl. Toxicol., 15, 221-230.
27. Schoof,R.A. and Baxter,C.S. (1986) Topical application of a tumor promoter induces proliferation of an adherent cell population in murine spleen. Int. J. Immunopharmacol., 8, 455-462.
28. Updyke,L.W., Yoon,H.L. and Pfeifer,R.W. (1991) Induction of granulocyte-macrophage colony-stimulating activity by 12-O-tetradecanoylphorbol-13-acetate in SENCAR and B6C3F1 mice. Carcinogenesis, 12, 735-739.
29. Chang,M.-P. and Norman,D.C. (1992) Mechanism of ethanol-mediated immunosuppression in mice: ethanol suppresses T-cell proliferation without affecting IL2 production and IL2 receptor expression. Int. J. Immunopharmacol., 14, 707-719.
30. LeVier,D.G. et al. (1994) Immunotoxicological profile of morphine sulfate in B6C3F1 female mice. Fundam. Apppl. Toxicol., 22, 525-542.
31. Muller,I. (1992) Role of T cell subsets during the recall of immunological memory to Leishmania major. Eur. J. Immunol., 22, 3063-3069.
32. Murray,M.J., Lauer,L.D., Luster,M.I., Luebke,R.W., Adams,D.O. and Dean,J.H. (1985) Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate. Int. J. Immunopharmacol., 7, 491-500.
33. Kranz,D.M., Pasternack,M.S. and Eisen,H.N. (1987) Recognition and lysis of target cells by cytotoxic T lymphocytes. Fedn Proc., 46, 309-312.
34. Prehn,R.T. and Lappe,M.A. (1971) An immunostimulation theory of tumor development. Transplant. Rev., 7, 26-54.
35. Prehn,R.T. and Prehn,L.M. (1987) The autoimmune nature of cancer. Cancer Res., 47, 927-932.
36. Robertson,F.M., Bijur,G.N., Oberyszyn,A.S., Nill,M.R., Boros,L.G., Spencer,W.J., Sabourin,C.L.K. and Oberyszyn,T.M. (1995) Interleukin-1α in murine multstage skin carcinogenesis. In Mukhtar,H. (ed.), Skin Cancer: Mechanism and Human Relevance. CRC Press, Boca Raton, FL, pp. 255-272.
37. Lee,W.Y. Lockniskar,M.F. and Fischer,S.M. (1994) Interleukin-1α mediates phorbol ester-induced inflammation and epidermal hyperplasia. FASEB J., 8, 1081-1087.
38. Robertson,F.M., Bijur,G.N., Oberyszyn,A.S., Pellegrini,A.E., Boros,L.G., Sabourin,C.L.K. and Oberyszyn,T.M. (1994) Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion. Carcinogenesis, 15, 1017-1029.
39. Burnet,F.M. (1970) The concept of immunological surveillance. Prog. Exp. Tumor Res., 13, 1-27.
40. Reiners,J.J.,Jr, Yoon,H.L. and Singh,K.P. (1995) Roles of immunosurveillance and immunostimulation in the process of chemical carcinogenesis in murine skin. In Mukhtar,H. (ed.), Skin Cancer: Mechanism and Human Relevance. CRC Press, Boca Raton, FL, pp. 237-254.
41. Anderson,L.M. and Rice,J.M. (1987) Tumorigenesis in athymic nude mouse skin by chemical carcinogens and ultraviolet light. J. Natl Cancer Inst., 78, 125-134.
42. Schjerven,L., Elgjo,K., Iverson,O.H. and Palbo,V. (1974) Skin carcinogenesis in nude mice. In Rygaard,J. and Poulsen,C.O. (eds), Proceedings of the 1st International Workshop on Nude Mice. Gustav Fisher-Verlag, Stuttgart, Germany, p. 265.
43. DiGiovanni,J., Walker,S.C., Beltran,L., Naito,M. and Eastin,W.C.Jr (1991). Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents. Cancer Res., 51, 1398-1405.
44. Eastin,W.C.,Jr (1989). Developing standards for dermal initiation/ promotion screening studies. In Slaga,T.J., Klein-Szanto,A.J.P., Boutwell,R.K., Stevenson,D.E., Spitzer,H.L. and D'Motto,B. (eds), Progress in Clinical and Biological Research. Alan R.Liss Inc., New York, NY, pp. 295-312.
45. Reiners,J.J.,Jr, Nesnow,S. and Slaga,T.J. (1984) Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis, 5, 301-307.
46. Hennings,H., Devor,D., Wenk,M.L., Slaga,T.J., Former,B., Colburn,N.H., Bowden,G.T., Elgjo,K. and Yuspa,S.H. (1981) Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res., 41, 773-779.
47. Singh,K.P., Yoon,H.Y., Ratner,S. and Reiners,J.J.,Jr (1996) Modulation of the development of humoral immunity by topically applied acetone, ethanol and 12-O-tetradecanoylphorbol-13-acetate. Fundam. Appl. Toxicol., 33, 129-139.
48. Kripke,M.L. and Morison,W.L. (1986) Studies on the mechanism of systemic suppression of contact hypersensitivity by UV-B radiation. Differences in the suppression of delayed and contact hypersensitivity in mice. J. Invest. Dermatol., 86, 543-549.
49. Schwarz,A. et al. (1994) In vivo effects of interleukin-10 on contact hypersensitivity and delayed hypersensitivity reactions. J. Invest. Dermatol., 103, 211-216.
50. Roeser,H., Doege,T. and Hecker,E. (1991) Toxicokinetics of tumour promoters of mouse skin. II. Metabolism of the tumour promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin and biological activities of metabolites. Carcinogenesis, 12, 1563-1570.
51. Berry,D.L., Bracker,W.M., Fischer,S.M., Viaje,A. and Slaga,T.J. (1978) Metabolic conversion of 12-O-tetradecanoylphorbol-13-acetate in adult and newborn mouse skin and mouse liver microsomes. Cancer Res., 38, 2301-2306.
52. Kadner,S.S., Katz,J.H., Levitz,M. and Finlay,T.H. (1985) The 65-KDa phorbol-diester hydrolase in mouse plasma is esterase 1 and is immunologically distict from the 56-KDa phorbol diester hydrolase in mouse skin. J. Biol. Chem., 260, 15604-15609.